Members     Feedback     Sitemap     Help     EN  
  
You are here: Homepage > News > Story
   
 
   Home
   Products
   Market&Application
   Environmental Aspects
   Locations
   About Us
   Certificates
 
   Contacts
   Library
   News
   Links
   Imprint

   News Story


23/09/2005 - Solkane®134a pharma recommendation by European Health Authorities
Contact for more info about this document
  

Solkane ®134a pharma recommendation stated as CFC replacement in MDI's in Europe

Solkane® 134a pharma, better known as Norflurane in pharmaceutical world, is recommended by the European Health Authorities for use as propellant in MDI (Medical Dose Inhaler).


Contacts for more info
  

Michael.Pittroff@solvay.com

Peter.Jannick@solvay.com

 

 




 
Back

   
 
© 1996-2001, Solvay S.A. • Disclaimer and Privacy Policy • If you have any comment on this website, please contact the webmaster. • Engineered by Digital Age Design